Abbott India Cash Flow | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Abbott India Ltd.

Abbott India Ltd. | Cash Flow

Fiscal year is April-March. All values INR Millions.

2014

2015

2016

2017

2018

Net Income before Extraordinaries

2,946

3,444

3,980

4,365

6,215

Depreciation, Depletion & Amortization

219

149

146

166

176

Other Funds

981

1,286

1,367

1,573

2,366

Funds from Operations

2,183

2,307

2,759

2,958

4,025

Changes in Working Capital

316

235

218

665

1,870

Net Operating Cash Flow

1,868

2,542

2,977

3,623

2,155

Capital Expenditures

181

271

215

243

Sale of Fixed Assets & Businesses

140

Purchase/Sale of Investments

1,713

2,107

1,046

1,894

1,051

Net Investing Cash Flow

1,754

2,263

1,272

2,107

2,778

Cash Dividends Paid - Total

423

575

793

895

1,023

Net Financing Cash Flow

423

575

793

895

1,023

Net Change in Cash

309

295

912

620

1,646

Free Cash Flow

1,700

2,361

2,714

3,416

1,988

Other Sources

1,900

514

Other Uses

1,900

2,000

About Abbott India

View Profile

Address	16th Floor, Godrej BKC Mumbai Maharashtra 400051 India
Employees	-
Website	http://www.abbott.co.in
Updated	09/14/2018
Abbott India Ltd. is a pharmaceutical company, which develops, manufactures and markets pharmaceutical, diagnostic, nutritional, and hospital products. Its products include ebasil, solspre, citrosoda, digenewas, actnew, acuvin, and acevah. The company was founded on August 22, 1944 and is headquartered in Mumbai, India.